PharmaCielo Ltd. (TSXV:PCLO)
Canada · Delayed Price · Currency is CAD 0.0550
0.00 (0.00%)
Sep 18, 2026, 1:13 PM EST
PharmaCielo Financials Overview
Financials in millions CAD. Fiscal year is April - March.
Millions CAD. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Revenue Revenue Growth | 3.6 | 2.54 | 3.17 | 3.48 | 1.54 | 5.31 |
Revenue Growth | 32.87% | -20.08% | -8.81% | 125.70% | -70.96% | 172.93% |
Gross Profit Gross Profit Growth | 1.3 | 0.73 | 0.37 | 0.73 | -1.37 | 1.04 |
Operating Income Operating Income Growth | -3.13 | -3.19 | -4.72 | -4.67 | -9.95 | -10.93 |
Net Income Net Income Growth | -3.71 | -3.58 | -9.1 | -9.14 | -16.3 | -14.52 |
Earnings Per Share EPS Growth | -0.02 | -0.02 | -0.05 | -0.05 | -0.10 | -0.10 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Americas Americas Growth | 3.11 | 2.12 | 1.58 | 1.58 | 1.32 | 4.96 |
Europe Europe Growth | - | 0.04 | 0.18 | 0.23 | 0.05 | 0.35 |
Australia Australia Growth | - | 0.37 | 0.64 | 0.7 | 0.13 | - |
Africa Africa Growth | - | - | 0.78 | 0.98 | 0.04 | - |
Total Total Growth | 3.6 | 2.54 | 3.17 | 3.48 | 1.54 | 5.31 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Cash & Investments Cash & Investments Growth | 0.08 | 0.02 | 0.05 | 0.15 | 0.06 | 0.33 |
Total Debt Total Debt Growth | 18.21 | 18.16 | 22.23 | 20.52 | 18.31 | 12.59 |
Net Cash (Debt) Net Cash Growth | -18.14 | -18.14 | -22.18 | -20.38 | -18.25 | -12.26 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.09 | -0.10 | -0.13 | -0.12 | -0.11 | -0.08 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -6.96 | -4.61 | -1.69 | -1.97 | -5.15 | -9.88 |
Capital Expenditures CapEx Growth | - | - | - | - | -0.02 | -0.52 |
Free Cash Flow Free Cash Flow Growth | -6.96 | -4.61 | -1.69 | -1.97 | -5.17 | -10.4 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Gross Margin | 36.19% | 28.59% | 11.77% | 21.00% | -88.78% | 19.55% |
Operating Margin | -86.73% | -125.75% | -148.74% | -134.06% | -645.41% | -205.85% |
Pretax Margin | -103.08% | -141.06% | -286.63% | -262.70% | -1057.09% | -273.45% |
Profit Margin | -103.08% | -141.06% | -286.63% | -262.70% | -1057.09% | -273.45% |
FCF Margin | -193.01% | -181.86% | -53.10% | -56.59% | -335.01% | -195.86% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 20, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Forward PE | - | 9.08 | 9.08 | 9.08 | 9.08 | 9.08 |
PS Ratio | 3.37 | 3.16 | 3.85 | 4.04 | 19.26 | 4.99 |